NASDAQ: EZRAReliance Global Group Inc Stock
$2.09-0.06 (-2.79%)
Updated Jul 27, 2026
EZRA Price
$2.09
Fair Value Price
N/A
Market Cap
$1.16M
52 Week Low
$2.03
52 Week High
$78.00
P/E
-0.05x
P/B
0.16x
P/S
0.25x
PEG
N/A
Dividend Yield
57.42%
Revenue
$12.02M
Earnings
-$6.72M
Gross Margin
60.7%
Operating Margin
-48.89%
Profit Margin
-55.9%
Debt to Equity
0.86
Operating Cash Flow
-$4M
Beta
0.72
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
EZRA Overview
Reliance Global Group, Inc. acquires, owns, and manages insurance distribution and technology-oriented businesses in the United States. The company operates RELI Exchange, a business-to-business InsurTech platform and partner network designed to support insurance agents and agencies through technology-enabled tools and operational infrastructure; and 5MinuteInsure.com, a direct-to-consumer InsurTech platform designed to enable consumers to compare, quote, and bind certain insurance products through a streamlined digital interface. It also provides training and mentorship resources to support agent onboarding and business development through its platform; agency services for insurance products in the healthcare, life, bond, auto, and property and casualty sectors; and insurance marketing services. The company was formerly known as Ethos Media Network, Inc. and changed its name to Reliance Global Group, Inc. in October 2018. The company was incorporated in 2013 and is headquartered in Lakewood, New Jersey.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine EZRA's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +5.11% per year. Learn More
Zen Rating Component Grades
F
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Be the first to know about important EZRA news, forecast changes, insider trades & much more!
EZRA News
Overview
Due Diligence Score
–
Industry Average (33)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how EZRA scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
EZRA is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
EZRA is good value based on its book value relative to its share price (0.16x), compared to the US Insurance Brokers industry average (4.12x)
P/B vs Industry Valuation
EZRA is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 35 more EZRA due diligence checks available for Premium users.
Valuation
EZRA price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.05x
Industry
25x
Market
14.17x
EZRA price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.16x
Industry
4.12x
EZRA is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
EZRA's financial health
Profit margin
Revenue
$3.8M
Net Income
-$1.5M
Profit Margin
-38.4%
EZRA's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
EZRA's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$13.8M
Liabilities
$6.4M
Debt to equity
0.86
EZRA's short-term assets ($4.46M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
EZRA's long-term liabilities ($4.51M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
EZRA's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
EZRA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$571.2k
Investing
-$500.0k
Financing
$1.6M
EZRA's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
EZRA vs Insurance Stocks
Reliance Global Group Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.